CFDB - Cystic Fibrosis DataBase

at least one term
all terms
All subcategories » published, non RCT

Airway clearance therapy in the school environment: Retrospective analysis of a cohort of pediatric patients with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2023
  • Byrwa DJ

Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective review.

primary studies  published, non RCT

Details
  • 2024
  • Guenther EL

Peri-operative and long-term outcomes of kidney transplantation in patients with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2024
  • O'Kelly JA

Improvement in Lung Clearance Index and Chest CT Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Study.

primary studies  published, non RCT

Details
  • 2023
  • McNally P

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.

primary studies  published, non RCT

Details
  • 2023
  • Grancini V

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data.

primary studies  published, non RCT

Details
  • 2023
  • Granger E

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.

primary studies  published, non RCT

Details
  • 2023
  • McElvaney OJ

Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease.

primary studies  published, non RCT

Details
  • 2023
  • Siegel MJ

Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

primary studies  published, non RCT

Details
  • 2021
  • Barreda CB

Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis.

primary studies  published, non RCT

Details
  • 2022
  • Berg P